193 related articles for article (PubMed ID: 17889375)
21. Immunopharmacology of CpG DNA.
Dalpke A; Zimmermann S; Heeg K
Biol Chem; 2002 Oct; 383(10):1491-500. PubMed ID: 12452427
[TBL] [Abstract][Full Text] [Related]
22. Potentiation of TLR9 responses for human naïve B-cell growth through RP105 signaling.
Yamazaki K; Yamazaki T; Taki S; Miyake K; Hayashi T; Ochs HD; Agematsu K
Clin Immunol; 2010 Apr; 135(1):125-36. PubMed ID: 20133206
[TBL] [Abstract][Full Text] [Related]
23. CpG DNA stimulates autoreactive immature B cells in the bone marrow.
Azulay-Debby H; Edry E; Melamed D
Eur J Immunol; 2007 Jun; 37(6):1463-75. PubMed ID: 17474151
[TBL] [Abstract][Full Text] [Related]
24. Role of TLR9 in hepatic stellate cells and experimental liver fibrosis.
Gäbele E; Mühlbauer M; Dorn C; Weiss TS; Froh M; Schnabl B; Wiest R; Schölmerich J; Obermeier F; Hellerbrand C
Biochem Biophys Res Commun; 2008 Nov; 376(2):271-6. PubMed ID: 18760996
[TBL] [Abstract][Full Text] [Related]
25. DNA vaccines in sheep: CTLA-4 mediated targeting and CpG motifs enhance immunogenicity in a DNA prime/protein boost strategy.
Kennedy NJ; Spithill TW; Tennent J; Wood PR; Piedrafita D
Vaccine; 2006 Feb; 24(7):970-9. PubMed ID: 16242220
[TBL] [Abstract][Full Text] [Related]
26. Maternal treatment with a high dose of CpG ODN during gestation alters fetal craniofacial and distal limb development in C57BL/6 mice.
Prater MR; Johnson VJ; Germolec DR; Luster MI; Holladay SD
Vaccine; 2006 Jan; 24(3):263-71. PubMed ID: 16143434
[TBL] [Abstract][Full Text] [Related]
27. TLR9 expression is related to immune activation but is impaired in individuals with chronic immune activation.
Ayash-Rashkovsky M; Bentwich Z; Borkow G
Int J Biochem Cell Biol; 2005 Nov; 37(11):2380-94. PubMed ID: 16024265
[TBL] [Abstract][Full Text] [Related]
28. Agonists of Toll-like receptor 9 containing synthetic dinucleotide motifs.
Yu D; Putta MR; Bhagat L; Li Y; Zhu F; Wang D; Tang JX; Kandimalla ER; Agrawal S
J Med Chem; 2007 Dec; 50(25):6411-8. PubMed ID: 17988082
[TBL] [Abstract][Full Text] [Related]
29. Strong immunostimulation in murine immune cells by Lactobacillus rhamnosus GG DNA containing novel oligodeoxynucleotide pattern.
Iliev ID; Kitazawa H; Shimosato T; Katoh S; Morita H; He F; Hosoda M; Saito T
Cell Microbiol; 2005 Mar; 7(3):403-14. PubMed ID: 15679843
[TBL] [Abstract][Full Text] [Related]
30. Induction of lymphocytes activated marker CD69 following exposure to chitosan and alginate biopolymers.
Borges O; Borchard G; de Sousa A; Junginger HE; Cordeiro-da-Silva A
Int J Pharm; 2007 Jun; 337(1-2):254-64. PubMed ID: 17317051
[TBL] [Abstract][Full Text] [Related]
31. Mechanisms of TLR9 activation.
Latz E; Visintin A; Espevik T; Golenbock DT
J Endotoxin Res; 2004; 10(6):406-12. PubMed ID: 15588423
[TBL] [Abstract][Full Text] [Related]
32. The role of CpG dinucleotides in DNA vaccines.
Krieg AM; Yi AK; Schorr J; Davis HL
Trends Microbiol; 1998 Jan; 6(1):23-7. PubMed ID: 9481820
[TBL] [Abstract][Full Text] [Related]
33. CD44high memory CD8 T cells synergize with CpG DNA to activate dendritic cell IL-12p70 production.
Wong KL; Tang LF; Lew FC; Wong HS; Chua YL; MacAry PA; Kemeny DM
J Immunol; 2009 Jul; 183(1):41-50. PubMed ID: 19535645
[TBL] [Abstract][Full Text] [Related]
34. The effect of CpG sequences on the B cell response to a viral glycoprotein encoded by a plasmid vector.
Pasquini S; Deng H; Reddy ST; Giles-Davis W; Ertl HC
Gene Ther; 1999 Aug; 6(8):1448-55. PubMed ID: 10467369
[TBL] [Abstract][Full Text] [Related]
35. IFN-alpha amplifies human naive B cell TLR-9-mediated activation and Ig production.
Giordani L; Sanchez M; Libri I; Quaranta MG; Mattioli B; Viora M
J Leukoc Biol; 2009 Aug; 86(2):261-71. PubMed ID: 19401392
[TBL] [Abstract][Full Text] [Related]
36. TLR-9 activation aggravates concanavalin A-induced hepatitis via promoting accumulation and activation of liver CD4+ NKT cells.
Jiang W; Sun R; Zhou R; Wei H; Tian Z
J Immunol; 2009 Mar; 182(6):3768-74. PubMed ID: 19265155
[TBL] [Abstract][Full Text] [Related]
37. Identification of methylated CpG motifs as inhibitors of the immune stimulatory CpG motifs.
Chen Y; Lenert P; Weeratna R; McCluskie M; Wu T; Davis HL; Krieg AM
Gene Ther; 2001 Jul; 8(13):1024-32. PubMed ID: 11438837
[TBL] [Abstract][Full Text] [Related]
38. DNA methylation and TLR9 ligands: not only a matter of semantics.
Baldari CT
Immunol Lett; 2008 Nov; 121(1):84-5. PubMed ID: 18805440
[No Abstract] [Full Text] [Related]
39. Alpha 2-macroglobulin binds CpG oligodeoxynucleotides and enhances their immunostimulatory properties by a receptor-dependent mechanism.
Anderson RB; Cianciolo GJ; Kennedy MN; Pizzo SV
J Leukoc Biol; 2008 Feb; 83(2):381-92. PubMed ID: 17967834
[TBL] [Abstract][Full Text] [Related]
40. Enhanced B-cell activation mediated by TLR4 and BCR crosstalk.
Minguet S; Dopfer EP; Pollmer C; Freudenberg MA; Galanos C; Reth M; Huber M; Schamel WW
Eur J Immunol; 2008 Sep; 38(9):2475-87. PubMed ID: 18819072
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
